CRVS · Corvus Pharmaceuticals, Inc. · Documents
$10.53
-0.12 (-1.13%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$885.79M
Shares
84.12M
Volume · Oct 23
933.82K
Avg daily vol (3M)
991.43K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-06-21 | 2023-06-15 | |
| 8-K | — | 2023-05-08 | — | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| DEF 14A | — | 2023-04-28 | 2023-06-15 | |
| 8-K | — | 2023-04-24 | 2023-04-21 | |
| 8-K | — | 2023-04-03 | 2023-03-29 | |
| 8-K | — | 2023-03-29 | 2023-03-28 | |
| 10-K | — | 2023-03-28 | 2022-12-31 | |
| 8-K | — | 2023-03-28 | — | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K/A | — | 2022-11-03 | 2022-06-15 | |
| 8-K | — | 2022-11-03 | — | |
| 8-K | — | 2022-10-28 | 2022-10-25 | |
| 8-K | — | 2022-08-08 | — | |
| 10-Q | — | 2022-08-08 | 2022-06-30 | |
| 8-K | — | 2022-06-17 | 2022-06-15 | |
| 8-K | — | 2022-05-05 | — | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| DEF 14A | — | 2022-04-28 | 2022-06-15 | |
| 8-K | — | 2022-03-10 | — | |
| 10-K | — | 2022-03-10 | 2021-12-31 | |
| 8-K | — | 2021-11-02 | 2021-11-01 | |
| 10-Q | — | 2021-11-01 | 2021-09-30 | |
| 8-K | — | 2021-11-01 | — | |
| 8-K | — | 2021-08-02 | — | |
| 10-Q | — | 2021-08-02 | 2021-06-30 | |
| 8-K | — | 2021-07-15 | — | |
| 8-K | — | 2021-06-16 | 2021-06-15 | |
| 8-K | — | 2021-04-29 | — | |
| 10-Q | — | 2021-04-29 | 2021-03-31 | |
| DEF 14A | — | 2021-04-20 | 2021-06-15 | |
| 8-K | — | 2021-03-25 | — | |
| 10-K | — | 2021-03-25 | 2020-12-31 | |
| 8-K | — | 2021-03-22 | 2021-03-18 | |
| 8-K | — | 2021-02-17 | 2021-02-12 | |
| 8-K | — | 2021-02-11 | — | |
| 8-K | — | 2021-02-04 | — | |
| 8-K | — | 2020-12-17 | 2020-12-16 | |
| 8-K | — | 2020-12-07 | 2020-12-06 | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-10-29 | 2020-09-30 | |
| 8-K | — | 2020-10-29 | — | |
| 8-K | — | 2020-10-05 | — | |
| 8-K | — | 2020-09-17 | — | |
| 8-K | — | 2020-09-11 | 2020-09-10 | |
| 8-K | — | 2020-09-10 | — | |
| 10-Q | — | 2020-07-30 | 2020-06-30 | |
| 8-K | — | 2020-07-30 | — |
Showing 51–100 of 111 filings
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
16 filings
16 filers
Visit website
Investor relations